Skip to main content

Meta-analysis for Rare Events in Clinical Trials

  • Chapter
  • First Online:
Biopharmaceutical Applied Statistics Symposium

Part of the book series: ICSA Book Series in Statistics ((ICSABSS))

  • 663 Accesses

Abstract

Biopharmaceutical clinical trials are typically conducted globally with multi-center, multi-regional trials. Meta-analysis is a natural statistical method for combining the data from these trials to increase the reliability of statistical findings. Trials with rare events are not uncommon. This chapter presents an overview of meta-analysis to synthesize summary statistics from multiple clinical trials and then illustrate how to use R software to analyze clinical trials with rare events. we make use of the well-known Rosiglitazone meta-analysis data to illustrate the bias when classical meta-analysis methods are used for rare events and then introduce a R package gmeta for meta-analysis of rare events.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bhaumik, D. K., Amatya, A., Normand, S. T., Greenhouse, J., Kaizar, E., Neelon, B., et al. (2012). Meta-analysis of rare binary adverse event data. Journal of the American Statistical Association, 107(498), 555–567.

    Article  MathSciNet  Google Scholar 

  • Cai, T., Parast, L., & Ryan, L. (2010). Meta-analysis for rare events. Statistics in Medicine, 29(20), 2078–2089.

    Article  MathSciNet  Google Scholar 

  • Chen, D. G., & Peace, K. E. (2013). Applied meta-analysis using R. Chapman & Hall/CRC.

    Google Scholar 

  • Dahabreh, I. J. (2008). Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Clinical Trials, 5, 116–120.

    Article  Google Scholar 

  • DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.

    Article  Google Scholar 

  • Hardy, R. J., & Thompson, S. G. (1998). Detecting and describing heterogeneity in meta-analysis. Statistics in Medicine, 17, 841–856.

    Article  Google Scholar 

  • Harwell, M. (1997). An empirical study of hedges homogeneity test. Psychological Methods, 2, 219–231.

    Article  Google Scholar 

  • Lane, P. W. (2012). Meta-analysis of incidence of rare events. Statistical Methods in Medical Research (2012 Jan 4 Epub).

    Google Scholar 

  • Nissen, S. E., & Wolski, K. (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine, 356, 2457–2471.

    Google Scholar 

  • Raudenbush, S. W. and A. S. Bryk (1985). Empirical bayes meta-analysis. Journal of Educational Statistics, 10(2), 75–98.

    Google Scholar 

  • Shuster, J. J., Jones, L. S., & Salmon, D. A. (2007). Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine, 26(24), 4375–4385.

    Article  MathSciNet  Google Scholar 

  • Shuster, J. J., & Schatz, D. A. (2008). The rosigliazone meta-analysis: Lessons for the future. Diabetes Care, 31(3) (10 March 2008).

    Google Scholar 

  • Sutton, A. J., Cooper, N. J., Lambert, P. C., Jones, D. R., Abrams, K. R., & Sweeting, M. J. (2002). Meta-analysis of rare and adverse event data. Expert Review of Pharmacoeconomics and Outcomes Research, 2(4), 367–379.

    Article  Google Scholar 

  • Sweeting, M. J., Sutton, A. J., & Lambert, P. C. (2004). What to add to nothing? use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine, 23, 1351–1375.

    Article  Google Scholar 

  • Tian, L., Cai, T., Pfeffer, M., Piankov, N., Cremieux, P., & Wei, L. (2009). Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 by 2 tables with all available data but without artificial continuity correction. Biostatistics, 10(2), 275–281.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ding-Geng Chen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chen, DG., Peace, K.E. (2018). Meta-analysis for Rare Events in Clinical Trials. In: Peace, K., Chen, DG., Menon, S. (eds) Biopharmaceutical Applied Statistics Symposium . ICSA Book Series in Statistics. Springer, Singapore. https://doi.org/10.1007/978-981-10-7826-2_8

Download citation

Publish with us

Policies and ethics